Please login to the form below

Not currently logged in
Email:
Password:

Juventas

This page shows the latest Juventas news and features for those working in and with pharma, biotech and healthcare.

Astellas bulks up immuno-oncology pipeline with $665m Xyphos deal

Astellas bulks up immuno-oncology pipeline with $665m Xyphos deal

This includes a deal made in  2018, when Astellas bought out gene therapy biotech Juventas for an exclusive option on its non-viral gene therapy JVS-100.

Latest news

  • Astellas makes another gene therapy play with Juventas deal Astellas makes another gene therapy play with Juventas deal

    Targeting faecal incontinence, which affects 50m worldwide. Astellas has made another deal in the gene therapy category, licensing a candidate for treating faecal incontinence from US biotech Juventas Therapeutics. ... Juventas has previously shown that

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Heart failure therapy embarks on a new era Heart failure therapy embarks on a new era

    Among these, Juventas Therapeutics' non-viral gene therapy JVS-100 - which expresses stromal cell-derived factor-1 (SDF-1) and activates the body's own tissue repair pathways - has been

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...
How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...